Core Viewpoint - Hang Seng Bank has been actively repurchasing its shares, indicating a strategy to support its stock price amid recent declines [2] Summary by Category Share Buyback Activity - On August 6, Hang Seng Bank repurchased 200,000 shares at prices ranging from HKD 112.800 to HKD 113.600, totaling HKD 22.6347 million [2] - The stock closed at HKD 113.100 on the same day, reflecting a decrease of 0.44% with a total trading volume of HKD 343 million [2] - Since August 1, the bank has conducted share buybacks for four consecutive days, acquiring a total of 800,000 shares for a cumulative amount of HKD 90.6157 million [2] - During this period, the stock has experienced a total decline of 1.31% [2] Buyback Details - The buyback details for the past four days are as follows: - August 6: 20,000 shares at a maximum price of HKD 113.600 and a minimum price of HKD 112.800, totaling HKD 22.6347 million [2] - August 5: 20,000 shares at a maximum price of HKD 114.200 and a minimum price of HKD 113.100, totaling HKD 22.7170 million [2] - August 4: 20,000 shares at a maximum price of HKD 114.000 and a minimum price of HKD 111.900, totaling HKD 22.6719 million [2] - August 1: 20,000 shares at a maximum price of HKD 114.300 and a minimum price of HKD 112.400, totaling HKD 22.5922 million [2]

Performance Highlights - BeiGene (06160.HK) reported a revenue of 17.518 billion yuan for the first half of the year, a year-on-year increase of 46%; product revenue was 17.36 billion yuan, up 45.8%; net profit was 450 million yuan, turning from loss to profit [2] - Uni-President China (00220.HK) achieved approximately 17.087 billion yuan in revenue for the first half, a year-on-year increase of 10.6%; net profit was about 1.287 billion yuan, up 33.2% [2] - Zhiyu City Technology (09911.HK) announced a positive profit forecast, expecting mid-term revenue of approximately 3.135 to 3.215 billion yuan, a year-on-year increase of about 38.0% to 41.5%; net profit is expected to be around 470 to 510 million yuan, a year-on-year growth of approximately 108.9% to 126.7% [2] Earnings Forecasts - New World Development Company (00086.HK) expects mid-term net profit to increase to no less than 800 million HKD year-on-year [3] - Weizhi Jinkou (02003.HK) anticipates mid-term net profit exceeding 200 million HKD, a significant increase year-on-year [3] - Wing Chan Industrial (01596.HK) forecasts mid-term net profit of approximately 48.7 million HKD, turning from loss to profit [3] - Huaxian Optoelectronics (00334.HK) expects mid-term net profit to exceed 48.8 million HKD, a year-on-year increase of over 600% [3] - Maifushi (02556.HK) predicts mid-term net profit of approximately 31.8 to 41 million HKD, turning from loss to profit [4] - Xinwei Medical-B (06609.HK) expects mid-term net profit to exceed 40 million HKD, turning from loss to profit [5] - China Nuclear Technology (00611.HK) anticipates mid-term net profit growth of over 15% [6] Earnings Warnings - Hongxing Printing Group (00450.HK) expects mid-term net loss of approximately 49 million HKD, a significant increase year-on-year [7] - Zhongyu Land (01224.HK) forecasts mid-term net loss of approximately 40 million HKD, turning from profit to loss [7] - Beihai Group (00701.HK) anticipates mid-term net loss of 36 to 40 million HKD [8] Real Estate Sales Data - China Overseas Development (00688.HK) reported cumulative contract property sales of approximately 132 billion yuan for the first seven months, a year-on-year decrease of 18.3% [9] - Yuexiu Property (00123.HK) achieved cumulative contract sales of approximately 67.506 billion yuan for the first seven months, a year-on-year increase of about 11.7% [9] - Poly Property Group (00119.HK) reported contract sales of approximately 29.5 billion yuan for the first seven months, a year-on-year decrease of 13.49% [10] - China Overseas Hongyang Group (00081.HK) reported cumulative contract sales of 18.649 billion yuan for the first seven months, a year-on-year decrease of 12.2% [10] - Jindi Commercial Real Estate (00535.HK) reported cumulative contract sales of approximately 6.98 billion yuan for the first seven months, a year-on-year decrease of 37.37% [10] - Agile Group (03383.HK) reported pre-sale amount of approximately 5.69 billion yuan for the first seven months [11] - Hongyang Real Estate (01996.HK) reported cumulative contract sales of 3.208 billion yuan for the first seven months, a year-on-year decrease of 41.6% [12] - Zhengrong Real Estate (06158.HK) reported cumulative contract sales of approximately 2.701 billion yuan for the first seven months, a year-on-year decrease of 30.6% [12] - Jingrui Holdings (01862.HK) reported cumulative contract sales of approximately 571 million yuan for the first seven months, a year-on-year decrease of 52.54% [13] Company News - CITIC Securities (06030.HK) reported that its subsidiary, Huaxia Fund, achieved revenue of 4.258 billion yuan and net profit of 1.123 billion yuan in the first half, with assets under management totaling 285.1237 billion yuan [14] - Xinyi International (00732.HK) reported a cumulative operating revenue of approximately 9.566 billion HKD for the first seven months, a year-on-year decrease of about 5.3% [15] - Heng Rui Pharmaceutical (01276.HK) received orphan drug designation from the US FDA for its injection of Rikan Trastuzumab combined with Adebali for gastric cancer or gastroesophageal junction adenocarcinoma indications [15] - Fuhong Hanlin (02696.HK) completed the first patient dosing in a Phase II clinical study of HLX79 injection combined with Hanlikang® for active renal glomerulonephritis in China [15] - China Biopharmaceutical (01177.HK) announced that its self-developed TQ05105 (JAK/ROCK inhibitor) has been included in the breakthrough therapy designation program for the treatment of chronic graft-versus-host disease [15] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.65 billion HKD worth of about 1.714 million shares at a price of 95.8 to 96.75 HKD [16] - Hang Seng Bank (00011.HK) spent approximately 22.6347 million HKD to repurchase 200,000 shares at a price of 112.8 to 113.6 HKD [17] - Yum China (09987.HK) repurchased approximately 6.264 million HKD worth of 16,800 shares at a price of 369.8 to 376 HKD [17]

Group 1 - The company, Hang Seng Bank, announced a share buyback on August 6, 2023, spending HKD 22.63 million to repurchase 200,000 shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 恒生銀行有限公司 呈交日期： 2025年8月6日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | | 00011 | 說明 | 股份 | | | | | | 多櫃檯證券代號 | | 80011 | RMB 說明 | 股份 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股份（不包 ...

Summary of Key Points Core Viewpoint - On August 5, five Hong Kong-listed companies conducted share buybacks, totaling 795,900 shares and an aggregate amount of HKD 30.44 million [1][2]. Group 1: Buyback Details - Hang Seng Bank repurchased 200,000 shares for HKD 22.71 million, with a highest price of HKD 114.20 and a lowest price of HKD 113.10, bringing its total buyback amount for the year to HKD 67.98 million [1][2]. - Yuan Zheng Technology repurchased 433,500 shares for HKD 5.15 million, with a highest price of HKD 12.03 and a lowest price of HKD 11.23, totaling HKD 34.87 million in buybacks for the year [1][2]. - Miniso repurchased 32,400 shares for HKD 1.23 million, with a highest price of HKD 38.00 and a lowest price of HKD 37.82, accumulating HKD 322.36 million in buybacks for the year [1][2]. - In terms of buyback amounts, Hang Seng Bank led with HKD 22.71 million, followed by Yuan Zheng Technology with HKD 5.15 million [1][2]. - In terms of buyback volume, Yuan Zheng Technology had the highest with 433,500 shares, followed by Hang Seng Bank with 200,000 shares [1][2]. Group 2: Buyback Overview Table - A summary table lists the buyback activities of the companies, including their stock codes, names, number of shares repurchased, buyback amounts, highest and lowest prices, and total buyback amounts for the year [2].

自8月1日以来公司已连续3日进行回购，合计回购60.00万股，累计回购金额6798.11万港元。 其间该股 累计下跌0.87%。（数据宝） （原标题：恒生银行(00011.HK)连续3日回购，累计回购60.00万股） 证券时报•数据宝统计，恒生银行在港交所公告显示，8月5日以每股113.100港元至114.200港元的价格回 购20.00万股，回购金额达2271.70万港元。该股当日收盘价113.600港元，上涨0.09%，全天成交额3.35 亿港元。 | 日期 | 回购股数 （万股） | 回购最高价 （港元） | 回购最低价 （港元） | 回购金额 （万港元） | | --- | --- | --- | --- | --- | | 2025.08.05 | 20.00 | 114.200 | 113.100 | 2271.70 | | 2025.08.04 | 20.00 | 114.000 | 111.900 | 2267.19 | | 2025.08.01 | 20.00 | 114.300 | 112.400 | 2259.22 | 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 恒生银 ...

8月5日，恒生银行回购20.00万股股票，每股回购均价113.58港元，共耗资约2271.70万港元，本年累计 回购60.00万股，占总股本0.03%。 截至当日港股收盘，恒生银行上涨0.09%，报113.6港元/股。 恒生银行是一家在香港具有重要地位的金融机构。恒生银行于1933年3月3日创立，总部位于香港。它主 要提供广泛的银行及金融服务，包括零售银行及财富管理、商业银行、环球银行及资本市场服务等。恒 生银行在香港拥有庞大的分行网络，在当地金融市场占据相当的份额，并且在国际金融领域也有一定的 影响力。其业务涵盖了存款、贷款、信用卡、投资、保险等多个金融领域，以服务优质、创新能力较强 而闻名，在香港的金融体系稳定和发展过程中扮演着重要的角色。 本文源自：金融界 作者：港股君 恒牛银行沂期回购情况 回购日期回购均价回购股数回购金额本年累计回购股数2025-08-05113.58520.00万2271.70万60.00万2025- 08-04113.35920.00万2267.19万40.00万2025-08-01112.96120.00万2259.22万20.00万2024-09-0991.76146.86 ...

Performance Summary - Techtronic Industries (00669.HK) reported a revenue of $7.8 billion for the first half of the year, an increase of 7.5% year-on-year, with a net profit of $628 million, up 14.2% [1] - Yum China (09987.HK) achieved revenue of $2.8 billion in Q2 2025, a 4% increase year-on-year, with an operating profit of $304 million, up 14% [1] - Shiseido (02145.HK) expects mid-term revenue of approximately ¥4.09-4.11 billion, a year-on-year increase of about 16.8%-17.3%, and a net profit of approximately ¥540-560 million, up about 30.9%-35.8% [1] - Prosperity Industrial Trust (00778.HK) reported revenue of approximately HK$854 million for the first half, a decrease of about 2% year-on-year, while distributable income to unitholders increased by 2.06% to HK$377 million [1] - Zibuyu (02420.HK) anticipates mid-term revenue of approximately RMB 1.9-2.047 billion, a year-on-year increase of about 30%-40%, with a net profit of approximately RMB 100-110 million, up about 10%-20% [1] - Angelalign Technology (06699.HK) expects mid-term net profit of approximately $13.4-14.8 million, a year-on-year increase of approximately 538.1%-604.8% [1] Company News - Sunac China (01918.HK) reported a cumulative contract sales amount of ¥25.08 billion for the first seven months of 2025, a decrease of 9.43% year-on-year, with July contract sales of approximately ¥1.53 billion, an increase of 8.51% [3] - Xingye Holdings (00132.HK) entered into a financing lease agreement with Heilongjiang Mudanjiang Agricultural Reclamation Xinneng Thermal Power, involving an investment of ¥100 million [3] - China Biopharmaceutical (01177.HK) received NMPA approval for the clinical trial application of TQC3302, an ICS/LAMA/LABA soft mist inhalation formulation for the maintenance treatment of chronic obstructive pulmonary disease [3] Buyback Activities - HSBC Holdings (00005.HK) repurchased approximately 1.05 million shares at a cost of about HK$105 million, with buyback prices ranging from HK$95.35 to HK$96.3 [3] - Hang Seng Bank (00011.HK) repurchased 200,000 shares at a cost of approximately HK$22.717 million, with buyback prices between HK$113.1 and HK$114.2 [4]

恒生银行(00011)公布，2025年8月5日耗资约2271.7万港元回购20万股股份。 ...

格隆汇8月5日丨恒生银行(00011.HK)公告，8月5日耗资2272万港元回购20万股。 ...